Germany Neuraminidase Inhibitors Market (2025-2031) | Value, Companies, Size & Revenue, Competitive Landscape, Analysis, Outlook, Segmentation, Growth, Trends, Forecast, Share, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Germany Country Macro Economic Indicators

3.2 Germany Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F

3.3 Germany Neuraminidase Inhibitors Market - Industry Life Cycle

3.4 Germany Neuraminidase Inhibitors Market - Porter's Five Forces

3.5 Germany Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 Germany Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 Germany Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Germany Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F

3.9 Germany Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of influenza and other respiratory diseases in Germany

4.2.2 Growing awareness about the benefits of neuraminidase inhibitors in treating influenza

4.2.3 Rising healthcare expenditure and government initiatives to improve access to antiviral drugs

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval and market entry

4.3.2 Competition from generic drugs and alternative treatment options

4.3.3 Potential side effects and safety concerns associated with neuraminidase inhibitors

6.1 Germany Neuraminidase Inhibitors Market, By Indication

6.1.1 Overview and Analysis

6.1.2 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F

6.1.4 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F

6.1.5 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.2 Germany Neuraminidase Inhibitors Market, By Product

6.2.1 Overview and Analysis

6.2.2 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F

6.2.3 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F

6.2.4 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F

6.2.5 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F

6.2.6 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F

6.3 Germany Neuraminidase Inhibitors Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F

6.3.4 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.5 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.4 Germany Neuraminidase Inhibitors Market, By End User

6.4.1 Overview and Analysis

6.4.2 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.5 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.5 Germany Neuraminidase Inhibitors Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 Germany Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7.1 Germany Neuraminidase Inhibitors Market Export to Major Countries

7.2 Germany Neuraminidase Inhibitors Market Imports from Major Countries

8.1 Patient adherence rate to neuraminidase inhibitor treatment

8.2 Rate of prescription of neuraminidase inhibitors by healthcare providers

8.3 Number of clinical trials and research studies on neuraminidase inhibitors conducted in Germany.

9.1 Germany Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 Germany Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 Germany Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Germany Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F

9.5 Germany Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Germany Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024

10.2 Germany Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters